Table II.
Number of patients (event) divided by each gene cutoff value.
| Gene | Group | TCGA | GSE21501 |
|---|---|---|---|
| Total values (n) | All patients | 172 | 102 |
| PSEN1 | High expression (event) | 107 (68) | 61 (42) |
| Low expression (event) | 65 (24) | 41 (24) | |
| APH1A | High expression (event) | 75 (49) | 68 (49) |
| Low expression (event) | 97 (43) | 34 (17) | |
| PSENEN | High expression (event) | 101 (57) | 56 (40) |
| Low expression (event) | 71 (35) | 46 (26) | |
| NCSTN | High expression (event) | 127 (74) | 57 (38) |
| Low expression (event) | 45 (18) | 45 (28) | |
| PSEN2 | High expression (event) | 79 (39) | 86 (59) |
| Low expression (event) | 93 (53) | 16 (7) | |
| APH1B | High expression (event) | 37 (10) | 69 (47) |
| Low expression (event) | 135 (82) | 33 (19) |
PSEN, presenilin; APH1, anterior pharynx-defective 1; PSENEN, presenilin enhancer protein 2; NCSTN, nicastrin.